• Return to Headlines

Chemocentryx Inc Shares Down 46.9% Since SmarTrend's Sell Call (CCXI)

By Nick Russo

SmarTrend identified a Downtrend for Chemocentryx Inc (NASDAQ:CCXI) on April 15th, 2019 at $12.97. In approximately 4 months, Chemocentryx Inc has returned 46.93% as of today's recent price of $6.88.

In the past 52 weeks, Chemocentryx Inc share prices have been bracketed by a low of $6.19 and a high of $14.90 and are now at $6.88, 11% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 3.2% while the 200-day MA has slid 0.6%.

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, develops new medications for inflammatory and autoimmune diseases, and cancer in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Chemocentryx Inc.

Log in and add Chemocentryx Inc (CCXI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights chemocentryx inc

Ticker(s): CCXI